Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	79.51	-126.50	70.47
Graham Fair Price	-16.08	0.53	0.63
PEG	-56.10	0.22	-0.50
Price/Book	-16.06	2.59	3.08
Price/Cash Flow	364.71	1589.22	341.98
Prices/Earnings	15.51	-37.33	32.32
Price/Sales	400.54	182.44	36.45
Price/FCF	364.71	1589.22	341.98
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	9.85	-0.68	0.62
Operating Margin	275.08	-1.76	0.47
ROA	-27.57	< 0.005	0.01
ROE	0.02	-0.02	-27.33
ROIC	0.02	-0.02	-34.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.01	< 0.005	-217.78
Dividends QOQ	-0.08	< 0.005	93.93
EBIT QOQ	-0.45	-1.62	-259.36
EPS QOQ	-0.65	-1.72	-163.14
FCF QOQ	1.31	-0.82	-37.22
Revenue QOQ	-0.30	-0.84	-175.47
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	82.26	110.66	34.52
Days Sales Outstanding (DSO)	109.83	494.51	350.23
Inventory Turnover	1.09	0.81	-25.66
Debt/Capitalization	0.29	0.29	0.36
Quick Ratio	-1.10	0.90	-18.19
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.86	1.00	16.18
Cash	-0.36	-0.37	-2.70
Capex	-0.03	< 0.005	-86.86
Free Cash Flow	< 0.005	< 0.005	-82.22
Revenue	0.07	0.01	-83.49
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.16	0.99	-13.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.76	-10.44	119.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating